IgG Subclass Antibody Response in Grass Pollen‐Allergic Patients Undergoing Specific Immunotherapy

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Allergy. European Journal of Allergy and Clinical Immunology

• Publication date

  1984-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1398-9995.1984.tb01965.xPMID 6496881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Three‐Layer Immunoradiometric Assay for Determination of IgG Subclass Antibodies in Human Sera (“IgG Subclass RAST”)

  1984cited by this paper
• Specific immunotherapy with purified grass pollen extracts.

  1984cited by this paper
• The IgG Subclass Distribution of Thyroglobulin Antibody Synthesized in Culture

  1983cited by this paper
• An Automated Particle Counting Immunoassay (PACIA) for Determination of Blocking Antibodies against Timothy Grass Pollen in Sera from Desensitized Allergies

  1983cited by this paper
• Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response.

  1983cited by this paper
• Immunotherapy with Grass Pollen Major Allergens

  1982cited by this paper
• Immunotherapy with grass pollen major allergens. Immunological results from a prospective 3-year double blind study.

  1982cited by this paper
• Monoclonal antibodies to immunoglobulin G4 induce histamine release from human basophils in vitro.

  1982cited by this paper
• Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy.

  1982cited by this paper
• Immunotherapy with Grass Pollen Major Allergens

  1982cited by this paper
• Correlation of IgG and IgE antibody levels to honey bee venom allergens with protection to sting challenge.

  1981cited by this paper
• IgG4 antibodies in Egyptian patients with schistosomiasis.

  1981cited by this paper
• Immunotherapy in Hay Fever with Two Major Allergens 19, 25 and Partially Purified Extract of Timothy Grass Pollen

  1980cited by this paper
• Immunotherapy in Hay Fever with Two Major Allergens 19, 25 and Partially Purified Extract of Timothy Grass Pollen

  1980cited by this paper
• Occupational Allergy in Nurses to a Bulk Laxative

  1979cited by this paper
• Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy.

  1976cited by this paper
• The IgG subclasses of antibodies to grass pollen allergens produced in hay fever patients during hyposensitization

  1976cited by this paper
• Immunotherapy: Mechanisms of action suggested by measurements of immunologic and cellular parameters.

  1975cited by this paper
• Gamma G4-Globulin Antibody causing Inhibition of Clotting Factor VIII

  1968cited by this paper

• The role of IgG1 and IgG4 as dominant IgE-blocking antibodies during allergen immunotherapy

  2024cites this paper
• Pru p 3-specific IgE affinity is crucial in severe peach-allergy patients

  2024cites this paper
• The role of IgG1 and IgG4 as dominant IgE-blocking antibodies shifts during allergen immunotherapy.

  2023cites this paper
• Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels

  2021cites this paper
• Validation of a Multiplex Assay for Measuring Specific IgG4

  2020cites this paper
• Measurement of Specific IgG Anti-Fel d 1 Antibodies.

  2019cites this paper
• Allergy

  2019cites this paper
• Understanding of the Molecular Mechanisms of Allergy.

  2019cites this paper
• Blocking antibodies induced by allergen‐specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model

  2018cites this paper
• Conformational IgE Epitope Mapping of Der p 2 and the Evaluations of Two Candidate Hypoallergens for Immunotherapy

  2018cites this paper
• PreventionandTreatmentof Glucocorticoid-induced Osteoporosis

  2017cites this paper
• Specific immunotherapy in allergic rhinitis.

  2017cites this paper
• Immunoglobulin G; structure and functional implications of different subclass modifications in initiation and resolution of allergy

  2017cites this paper
• Peptide based immunotherapy: a pivotal tool for allergy treatment.

  2014cites this paper
• Changes in IL-10 and specific antibodies associated to successful Dermatophagoides pteronyssinus immunotherapy in children during the first year of treatment.

  2013cites this paper
• Changes in IL-10 and specific antibodies associated to successful Dermatophagoides pteronyssinus immunotherapy in children during the first year of treatment.

  2013cites this paper
• Does Allergen Immunotherapy Alter the Natural Course of Allergic Disorders?

  2012cites this paper
• Recent Advances in Treatment Strategies for Atopic Dermatitis

  2012cites this paper
• Facilitated antigen presentation and its inhibition by blocking IgG antibodies depends on IgE repertoire complexity.

  2011cites this paper
• Immunotherapy for Inhalant Allergens

  2009cites this paper
• A review of allergen-specific immunotherapy in human and veterinary medicine.

  2009cites this paper
• Measurement of specific IgG anti-Fel d 1 antibodies.

  2008cites this paper
• Immunologische Verlaufsparameter unter spezifischer Immuntherapie

  2008cites this paper
• Understanding of the molecular mechanisms of allergy.

  2008cites this paper
• Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity.

  2008cites this paper
• Induction d’IgG spécifiques au cours d’une désensibilisation effectuée avec des allergènes recombinants

  2008cites this paper
• Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding.

  2007cites this paper
• Cytokines as a therapeutic target for allergic diseases: a complex picture.

  2006cites this paper
• "Reatividade anticórpica IgE, IgG1 e IgG4 específica a antígenos de pólen de Lolium multiflorum (Lam. 1779) em pacientes com polinose"

  2006cites this paper
• Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.

  2006cites this paper
• Safety and tolerability of grass pollen tablets in sublingual immunotherapy – a phase‐1 study

  2006cites this paper
• High-dose allergen exposure leads to tolerance

  2005cites this paper
• Peptide-based vaccination: where do we stand?

  2005cites this paper
• Igg subclass-restricted immune responses to allergens

  2004cites this paper
• Blocking antibodies in allergen immunotherapy: the Yin and Yang

  2004cites this paper
• Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut

  2004cites this paper
• Pattern for Induction of Protective IgE Binding but Retains Protein Folding Modulation of Recombinant Bet v 1 Reduces Allergy Vaccine Engineering : Epitope

  2004cites this paper
• Immunoautoradiographic and protein-A/gold labelling experiments for localization of pollen allergens using antisera from atopic human individuals

  2004cites this paper
• Allergy Vaccine Engineering: Epitope Modulation of Recombinant Bet v 1 Reduces IgE Binding but Retains Protein Folding Pattern for Induction of Protective Blocking-Antibody Responses1

  2004cites this paper
• Serum IgG4 anti-Fab antibodies in rheumatoid arthritis are constitutively expressed

  2004cites this paper
• Subclass distribution of human IgG autoantibodies in pemphigus

  2004cites this paper
• Response to Cat Allergen Events in Development of the Modified Th 2 HLA-DR 7-Restricted T Cell-Dependent A Role for IL-10-Mediated Hammer and

  2004cites this paper
• A Role for IL-10-Mediated HLA-DR7-Restricted T Cell-Dependent Events in Development of the Modified Th2 Response to Cat Allergen1

  2004cites this paper
• The Changes of Mite-Specific Immunoglobulin A and Transforming Growth Factor-β1 During Immunotherapy of Children with Dust Mite Allergy

  2003cites this paper
• Dominating IgE-Binding Epitope of Bet v 1, the Major Allergen of Birch Pollen, Characterized by X-ray Crystallography and Site-Directed Mutagenesis

  2003cites this paper
• Renaissance of the Blocking Antibody Concept in Type I Allergy

  2003cites this paper
• Antibody and Keratinocyte responses to Malassezia pachydermatis in dogs

  2003cites this paper
• Site-Directed Mutagenesis Characterized by X-ray Crystallography and the Major Allergen of Birch Pollen , Dominating IgE-Binding Epitope of Bet v 1 ,

  2003cites this paper
• A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract.

  2003cites this paper
• Immunotherapy update: mechanisms of action.

  2002cites this paper
• Evaluation of two grass pollen extracts for immunotherapy by serum determinations of specific IgE and IgG4 antibodies towards purified Timothy grass pollen allergens (Phl p 1, 2, 4, 5, 6, 7, 11, 12) in patients undergoing hyposensitization treatment

  2002cites this paper
• Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1 : Th2 cytokine ratios

  2002cites this paper
• Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.

  2001cites this paper
• The Human IgG Subclasses

  2001cites this paper
• Allergen immunotherapy: guidelines, update, and recommendations of the World Health Organization.

  2000cites this paper
• Regulation of the IgE allergic immune response by humoral and cellular factors

  2000cites this paper
• Changes in Cytokine Production In Vitro during the Early Phase of Birch‐Pollen Immunotherapy

  2000cites this paper
• Monitoring allergen immunotherapy of pollen‐allergic patients: the ratio of allergen‐specific IgG4 to IgG1 correlates with clinical outcome

  1999cites this paper
• Oligodeoxynucleotides containing CpG motifs induce IL‐12, IL‐18 and IFN‐γ production in cells from allergic individuals and inhibit IgE synthesis in vitro

  1999cites this paper
• Cluster versus conventional immunotherapy in patients allergic to Dermatophagoides pteronyssinus: a controlled study of in vivo and in vitro parameters.

  1999cites this paper
• Immunological Mechanisms Operative in Allergen–Specific Immunotherapy

  1999cites this paper
• The role of allergen‐specific T cells in the allergic immune response: relevance to allergy vaccination

  1999cites this paper
• The role of allergen-specific T cells in the allergic immune response: relevance to allergy vaccination

  1999cites this paper
• Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy

  1999cites this paper
• WHO見解書 : アレルゲン免疫療法:アレルギー疾患の治療ワクチン

  1998cites this paper
• Immunologic changes associated with allergen immunotherapy.

  1998cites this paper
• Allergen‐Specific increase in interleukin (IL)‐4 and IL‐5 secretion from peripheral blood mononuclear cells during birch‐pollen immunotherapy

  1998cites this paper
• Allergen-specific immunotherapy for allergic rhinitis: a new insight into its clinical efficacy and mechanism.

  1998cites this paper
• Allergen immunotherapy: therapeutic vaccines for allergic diseases

  1998cites this paper
• Mechanisms of allergen specific immunotherapy

  1998cites this paper
• The natural history of Apis‐specific IgG and IgG4 in beekeepers

  1997cites this paper
• Detection of mosquito saliva‐specific IgE antibodies by capture ELISA

  1997cites this paper
• Immunotherapy with allergens.

  1997cites this paper
• Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-gamma production in CD4+ T cells.

  1997cites this paper
• The role of IgG in type-I allergy: an unsolved problem.

  1997cites this paper
• Monomeric chemically modified allergens: immunologic and Physicochemical characterigation

  1996cites this paper
• A comparative study of IgG subclass antibodies in patients allergic to wasp or bee venom

  1994cites this paper
• A double‐blind, placebo‐controlled study of immunotherapy with an alginate‐conjugated extract of Parietaria Judaica in patients with Parietaria hay fever

  1994cites this paper
• Booster immunotherapy (BIT)

  1994cites this paper
• communications to the editorPectin-induced Occupational Asthma-To the Editor

  1993cites this paper
• Allerjen Spesifik İmmünoterapi

  1993cites this paper
• Effect of rush immunotherapy in house-dust-mite (HDM)-sensitive adult bronchial asthma: changes in in vivo and in vitro responses to HDM.

  1993cites this paper
• Specific humoral response to cows’ milk proteins and ovalbumin in children with atopic dermatitis

  1993cites this paper
• Complement activation and C3 allotype distribution in patients with bronchial asthma.

  1993cites this paper
• Bestimmung der Veränderungen Allergenspezifischer IgE-, IgG- und IgG-Subklassenreaktivitäten in den Sera hyposensibilisierter Birkenpollen-allergischer Patienten mit Hilfe der Immunoblottechnik — Korrelation mit Therapieerfolg?

  1993cites this paper
• Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis.

  1993cites this paper
• Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma.

  1992cites this paper
• Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass.

  1992cites this paper
• Serum IgG subclass antibodies to a variety of food antigens in patients with coeliac disease.

  1992cites this paper
• The change of allergen-specific IgG subclass antibodies during immunotherapy in mite-sensitive asthmatic children.

  1992cites this paper
• New concepts in immunotherapy.

  1992cites this paper
• SerumIgGsubclass antibodies toavariety offood antigens inpatients withcoeliac disease

  1992cites this paper
• Evidence of a common regulation of IgE and IgG‐subclass antibodies in humans during immunotherapy

  1992cites this paper
• Monitoring of mite Dermatophagoides farinae allergen‐specific IgG and IgG subclass distribution in patients on immunotherapy

  1992cites this paper
• Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemic area

  1992cites this paper
• [Inhibitory activity of mite IgG4, antibody on antigen-induced histamine release from human peripheral blood leukocytes].

  1992cites this paper
• Quantitative IgE- and IgG-subclass responses during and after long-term ragweed immunotherapy.

  1992cites this paper
• A computational approach to the description of individual immune responses

  1991cites this paper
• Disodium cromoglycate enhances ongoing immunoglobulin production in vitro in human B cells.

  1991cites this paper
• [Hyposensitization in allergic diseases of the respiratory tract: indications, effectiveness, management].

  1991cites this paper